Substituted hydantoins as MEK kinase inhibitors

Details for Australian Patent Application No. 2008341680 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Moliterni, John Anthony; Morales, Omar Jose; Chen, Shaoqing; Kong, Norman; Huby, Nicholas John Silvester

Agent Davies Collison Cave

Pub. Number AU-A-2008341680

PCT Pub. Number WO2009/080523

Priority 61/015,222 20.12.07 US; 61/103,259 07.10.08 US

Filing date 10 December 2008

Wipo publication date 2 July 2009

International Classifications

C07D 233/74 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4166 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 233/78 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/080523 Priority application(s): WO2009/080523

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008341708-Microorganisms for improving the health of individuals with disorders related to gluten ingestion

2008341678-4 -aminopyrimidine derivatives as histamine H4 receptor antagonists